World's Best Scientists 2026 revealed!
Nicholas F. LaRusso

Nicholas F. LaRusso

D-Index & Metrics

Medicine

D-Index
134
Citations
64921
World Ranking
2156
National Ranking
1218

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Nicholas F. LaRusso is affiliated with the Mayo Clinic in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Within these, they focus on several subfields, including Hepatology, Surgery, Epidemiology, Genetics, and Molecular Biology.

The scientist's research topics show a concentration on areas related to liver and biliary diseases. The main topics of their work include:

  • Liver Diseases and Immunity
  • Pediatric Hepatobiliary Diseases and Treatments
  • Genetic and Kidney Cyst Diseases
  • Liver Disease Diagnosis and Treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Liver physiology and pathology
  • Liver Disease and Transplantation

Their frequent co-authors include Gregory J. Gores, Christy E. Trussoni, Konstantinos N. Lazaridis, Steven P. O'Hara, and John E. Eaton, indicating ongoing collaborative research within their field.

Nicholas F. LaRusso's published work appears regularly in specialized venues with a focus on liver and gastrointestinal research. Their publications are most frequently found in these journals:

  • Hepatology
  • Journal of Hepatology
  • Gastroenterology
  • JHEP Reports
  • Hepatology Communications

Selected recent papers include:

  • "An aged immune system drives senescence and ageing of solid organs" (2021), published in Nature
  • "Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids" (2021), published in Cell Stem Cell
  • "A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis" (2020), published in Journal of Hepatology
  • "Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation" (2020), published in Hepatology
  • "Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes" (2020), published in EBioMedicine

Nicholas F. LaRusso has been recognized as a Member of the Association of American Physicians.

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

    Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif

  • The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs

    Yi-Yi Zhu;Tamara Tchkonia;Tamar Pirtskhalava;Adam C Gower

  • Biliary tract cancers

    Piet C. De Groen;Gregory J. Gores;Nicholas F. LaRusso;Leonard L. Gunderson

  • Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis

    Russell H. Wiesner;Patricia M. Grambsch;E. Rolland Dickson;Jurgen Ludwig

  • Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism.

    Meeta Jaiswal;Nicholas F. LaRusso;Lawrence J. Burgart;Gregory J. Gores

  • Clinicopathologic features of the syndrome of primary sclerosing cholangitis

    Russell H. Wiesner;Nicholas F. LaRusso

  • Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis.

    C Penna;R Dozois;W Tremaine;W Sandborn

  • An aged immune system drives senescence and ageing of solid organs.

    Matthew J. Yousefzadeh;Rafael R. Flores;Yi Zhu;Zoe C. Schmiechen

  • A Cellular Micro-RNA, let-7i, Regulates Toll-like Receptor 4 Expression and Contributes to Cholangiocyte Immune Responses against Cryptosporidium parvum Infection

    Xian Ming Chen;Patrick L. Splinter;Steven P. O'Hara;Nicholas F. LaRusso

  • Cholangiocarcinoma complicating primary sclerosing cholangitis.

    Charles B. Rosen;David M. Nagorney;Russell H. Wiesner;Robert J. Coffey

  • The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis

    Anand H Patel;Denise M Harnois;George G Klee;Nicholas F LaRusso

  • Current concepts. Primary sclerosing cholangitis.

    LaRusso Nf;Wiesner Rh;Ludwig J;MacCarty Rl

  • Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis

    I. W. Graziadei;R. H. Wiesner;P. J. Marotta;M. K. Porayko

  • Primary Sclerosing Cholangitis.

    Konstantinos N Lazaridis;Nicholas F LaRusso

  • Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis

    Jurgen Ludwig;Jurgen Ludwig;Steven S. Barham;Steven S. Barham;Nicholas F. Larusso;Nicholas F. Larusso;Lila R. Elveback;Lila R. Elveback

  • Recurrence of primary sclerosing cholangitis following liver transplantation

    Ivo W. Graziadei;Russell H. Wiesner;Kenneth P. Batts;Paul J. Marotta

  • Primary sclerosing cholangitis: findings on cholangiography and pancreatography

    R L MacCarty;N F LaRusso;R H Wiesner;J Ludwig

  • The cholangiopathies: disorders of biliary epithelia.

    Konstantinos N. Lazaridis;Mario Strazzabosco;Nicholas F. LaRusso

  • A Revised Natural History Model for Primary Sclerosing Cholangitis

    W. Ray Kim;Terry M. Therneau;Russell H. Wiesner;John J. Poterucha

  • The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing Cholangitis

    Cynthia Levy;James Lymp;Paul Angulo;Gregory J. Gores

Frequent Co-Authors

Gregory J. Gores
Gregory J. Gores Mayo Clinic
Keith D. Lindor
Keith D. Lindor Arizona State University
Xian Ming Chen
Xian Ming Chen Creighton University
Jurgen Ludwig
Jurgen Ludwig Mayo Clinic
Alan F. Hofmann
Alan F. Hofmann University of California, San Diego
Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Albert Parés
Albert Parés University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare, but not sure if becoming a doctor is the right fit? There are many respected online degree alternatives that can lead to well-paying, rewarding careers.

For those without a nursing background, entry level msn programs online provide a fast track to an advanced nursing credential—even for those with a non-nursing bachelor’s degree. Similarly, online adn programs for non nurses offer a more accessible pathway into nursing, allowing students to enter the field quickly.

If you are seeking a flexible and lucrative field outside of direct patient care, consider the growing area of healthcare administration. medical billing and coding schools that accept fafsa make education in this area more affordable, helping students qualify for financial aid.

Some students prefer programs without extensive admissions testing. Many nursing schools that don't require teas or hesi exams offer a streamlined application process for a smoother journey into the healthcare workforce.

Best Scientists Citing Nicholas F. LaRusso

Trending Scientists